Navigation Links
VITAS Innovative Hospice Care(R) Names Christopher Rieder Senior Vice President and Chief Information Officer
Date:2/24/2009

MIAMI, Feb. 24 /PRNewswire/ -- VITAS Innovative Hospice Care(R) announced today that Christopher Rieder has been named senior vice president and chief information officer. In his new position, Rieder will oversee planning and implementation of IT operations throughout VITAS to support the company's strategic direction.

Rieder has more than 20 years of IT experience with global organizations translating business objectives into technology solutions. He has worked extensively with pharmaceutical and biotechnology companies.

Rieder most recently was chief information officer and vice president at Parexel, Inc., a leading bio-pharmaceutical services organization. At Parexel, Rieder led the company's worldwide technology initiatives, including integration of technology solutions, information management and business processes. Prior to that position, Rieder served as vice president of information technology for Kos Pharmaceuticals, where he built a customer- centric IT division to improve the company's customer service operations.

"Chris's experience at the senior management level will make him a superb asset to our organization," said David Wester, VITAS president and chief financial officer. "His ability to bring a working knowledge of technology to corporate initiatives will help us continue to offer innovative solutions for providing exceptional end-of-life care to our patients and their families."

Rieder holds an MBA in information technology from American University in Washington, D.C., and a BSBA in business economics and pre-medicine from the University of Arizona. A member of the Society for Information Management, Rieder was a contributing author of the book, "Improving Technology ROI: Leading CTOs and CIOs on Making Successful Technology Investments, Maximizing Return on Investments, & Gaining a Competitive Edge (Inside the Minds)."

VITAS Innovative Hospice Care(R), a pioneer and leader in the hospice movement since 1978, is one of the nation's largest providers of end-of-life care. Headquartered in Miami, Florida, VITAS (pronounced VEE-tahs) operates 45 hospice programs in 16 states (California, Connecticut, Delaware, District of Columbia, Florida, Georgia, Illinois, Kansas, Michigan, Missouri, New Jersey, Ohio, Pennsylvania, Texas, Virginia and Wisconsin). A wholly-owned subsidiary of Chemed Corporation (NYSE: CHE), VITAS employs 9,079 professionals who care for terminally ill patients daily, primarily in the patients' homes, but also in the company's 25 inpatient hospice units as well as in hospitals, nursing homes and assisted living communities/residential care facilities for the elderly. At the conclusion of the fourth quarter of 2008, VITAS reported an average daily census of 11,627.


'/>"/>
SOURCE VITAS Innovative Hospice Care(R)
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Navitas Names Dr. Dean Gesme as Medical Director
2. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
3. Innovative Neurotronics, a Subsidiary of Hanger Orthopedic Group, Earns the 2007 da Vinci Award for the WalkAide System
4. CardioDynamics Receives FDA 510(k) Clearance for Innovative Clinical Parameters and Electronic Medical Record Compatibility
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
7. Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia
8. Innovative Fosshield(R) Antimicrobial Technology Shown to Continuously Kill MRSA Superbug
9. Ferndale and Foamix Enter Development of an Innovative Foam for the Treatment of Atopic Dermatitis
10. A&G Pharmaceutical Receives $870,000 Grant from Avon Foundation to Advance Innovative Blood Diagnostic Test for Early Detection of Breast Cancer
11. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... Oxitec CEO Hadyn Parry will testify ... before the United States House Committee on Science, Space and ... controlling the spread of the Aedes aegypti mosquito, ... (Logo: http://photos.prnewswire.com/prnh/20150630/227348 ) Oxitec has pioneered ... in Brazil , Panama ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... molecular nanotechnology, announced the winners for the 2015 Foresight Institute Feynman Prizes. ... given in two categories, one for experiment and the other for theory in ...
(Date:5/20/2016)... ... 20, 2016 , ... Kablooe Design, a leading provider of product design and ... anniversary of the business. “We have worked hard to build long-term relationships,” says President ... privilege and honor of serving their product design and development needs through the years.” ...
(Date:5/19/2016)... ... May 19, 2016 , ... Anton Paar USA, located in ... office building is complete. The new structure adds a third office building to the ... USA purchased 2.4 acres of land, along with office space adjacent to the ...
Breaking Biology Technology:
(Date:3/15/2016)... 15, 2016 Yissum Research Development Company ... company of the Hebrew University, announced today the formation ... technology of various human biological indicators. Neteera Technologies has ... from private investors. ... detection of electromagnetic emissions from sweat ducts, enables reliable ...
(Date:3/10/2016)... India , March 10, 2016 ... a new market research report "Identity and Access Management ... & Audit, Compliance, and Governance), by Organization Size, by ... to 2020", published by MarketsandMarkets, The market is estimated ... USD 12.78 Billion by 2020, at a Compound Annual ...
(Date:3/8/2016)... March 8, 2016   Valencell , the ... announced it has secured $11M in Series D ... a new venture fund being launched by UAE-based ... from existing investors TDF Ventures and WSJ Joshua ... continue its triple-digit growth and accelerate its pioneering ...
Breaking Biology News(10 mins):